Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
Нано-составы полифенолов для терапии рака: экспериментальные данные и клиническая перспектива
2017-04-01
SCID: 54.1/xdd7cxcz
Discuss with AI
cancer therapydrug bioavailabilitynatural polyphenolspolyphenol nanoformulationstargeted therapy
Figures from the paper
Abstract (AI)
Cancer is defined as the abnormal cell growth that can cause life-threatening malignancies with high financial costs for patients as well as the health care system. Natural polyphenols have long been used for the prevention and treatment of several disorders due to their antioxidant, anti-inflammatory, cytotoxic, antineoplastic, and immunomodulatory effects discussed in the literature; thus, these phytochemicals are potentially able to act as chemopreventive and chemotherapeutic agents in different types of cancer. One of the problems regarding the use of polyphenolic compounds is their low bioavailability. Different types of formulations have been designed for the improvement of bioavailability of these compounds, nanonization being one of the most notable approaches among them. This study aimed to review current data on the nanoformulations of natural polyphenols as chemopreventive and chemotherapeutic agents and to discuss their molecular anticancer mechanisms of action. Nanoformulations of natural polyphenols as bioactive agents, including resveratrol, curcumin, quercetin, epigallocatechin-3-gallate, chrysin, baicalein, luteolin, honokiol, silibinin, and coumarin derivatives, in a dose-dependent manner, result in better efficacy for the prevention and treatment of cancer. The impact of nanoformulation methods for these natural agents on tumor cells has gained wider attention due to improvement in targeted therapy and bioavailability, as well as enhancement of stability. Today, several nanoformulations are designed for delivery of polyphenolic compounds, including nanosuspensions, solid lipid nanoparticles, liposomes, gold nanoparticles, and polymeric nanoparticles, which have resulted in better antineoplastic activity, higher intracellular concentration of polyphenols, slow and sustained release of the drugs, and improvement of proapoptotic activity against tumor cells. To conclude, natural polyphenols demonstrate remarkable anticancer potential in pharmacotherapy; however, the obstacles in terms of their bioavailability in and toxicity to normal cells, as well as targeted drug delivery to malignant cells, can be overcome using nanoformulation-based technologies, which optimize the bioefficacy of these natural drugs.
Key Findings
1
Nanoformulations of resveratrol, curcumin, quercetin, EGCG, and other polyphenols show dose-dependent improvements in cancer prevention and treatment.
2
Nanonization addresses polyphenols’ low bioavailability and can improve their efficacy as chemopreventive and chemotherapeutic agents.
3
Nanosuspensions, solid lipid nanoparticles, liposomes, gold nanoparticles, and polymeric nanoparticles improve targeting, stability, intracellular polyphenol concentration, and sustained drug release.
4
Natural polyphenols have anticancer potential through antioxidant, anti-inflammatory, cytotoxic, antineoplastic, and immunomodulatory activities.
5
Polyphenol nanoformulations enhance proapoptotic and antineoplastic effects against tumor cells, although the abstract is truncated before detailed clinical conclusions.
Research Object
Nanoformulations of natural polyphenols for cancer prevention and treatment
Research Subject
Their anticancer efficacy, bioavailability, stability, drug release, intracellular delivery, and molecular mechanisms of action
Publication Details
Publication Date
2017-04-01
Journal
Publisher
ISSN
Cited by
283
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest